Despite all the variations and versions they used, the limitations, injecting only one tumor, patients already had exhausted their treatment options and would be headed to hospice, the patients did very well, plus they worked to validate the responses to the treatment including a systemic response despite being limited to only one tumor and with patients who were metastatic.
Galzus has nothing better to do apparently, for all of his immense claims to being a fantastically successful person, than to harangue penny stock investors on this obscure board, 24-7-365, well, for him just since April under his current guise.
Market Data 
Markets 
AI
